Acknowledgement
Supported by : 전북대학교병원
References
- Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor- binding proteins in serum and other biological fluids : regulation and functions. Endocr Rev 1997;18:801-31 https://doi.org/10.1210/er.18.6.801
- Daughaday WH, Rotwein P. Insulin-like growth factors I and II : peptide messenger ribonucleic acid and gene structures serum and tissue concentrations. Endocr Rev 1989;10: 68-91 https://doi.org/10.1210/edrv-10-1-68
- Foustion AS, Leoff EB, Shipley GD, Moses HL. Growth factors and cnacer. Cancer Res 1986;46:1015-29
- Froesch ER, Schmidt Chr, Schwander J, Zapf J. Action of insulin-like growth factors. Annu Rev Physiol 1985;47:443- 67 https://doi.org/10.1146/annurev.ph.47.030185.002303
- Blatt J, White C, Dienes S, Friedman H, Foley T. Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Commun 1984;123:373-9 https://doi.org/10.1016/0006-291X(84)90423-6
- Reeve AE, Eccles MR, Wilkins RJ, Bell GI, Millow LJ. Expression of insulin-like growth factor II transcripts in Wilm's tumor. Nature 1985;317:258-60 https://doi.org/10.1038/317258a0
- Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169-73
- Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB. Secretion of an insulin-like growth factor- I-related protein by human breast cancer cells. Cancer Res 1986;46:4613-9.
- Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC, Cavenee WK. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985;316:330-4 https://doi.org/10.1038/316330a0
- Huff KK, Knabbe C, Lindsey R, kaufman D, Bronzert D, Lippman ME, et al. Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 1988;2:200-8 https://doi.org/10.1210/mend-2-3-200
- Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor- binding proteins in serum and other biological fluids : regulation and functions. Endocr Rev 1997;18:801-31 https://doi.org/10.1210/er.18.6.801
- Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Progress Growth Factor Res 1991;3:243-66 https://doi.org/10.1016/0955-2235(91)90003-M
- Oh Y, Muller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor(IGF)-independent action of IGF-binding protein- 3 in Hs578T human breast cancer cells. J Biol Chem 1993;268:14964-71
- Oh Y. IGFBPs and neoplastic models : new concept for roles of IGFBPs in regulation of cancer cell growth. Endocrine 1997;7:111-3 https://doi.org/10.1007/BF02778076
-
Oh Y, Muller HL, Ng L, Rosenfeld RG. Transforming growth factor-
${\beta}$ -induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995;270: 13589-92 https://doi.org/10.1074/jbc.270.23.13589 -
Gucev ZS, Oh Y, Kelly KM, Rosenfeld RG. Insulin-like growth factor binding protein 3 mediates retinoic acid and transforming growth factor
${\beta}$ 2-induced growth inhibition in human breast cancer cells. Cancer Res 1996;56:1545-50 - Huynh H, Yang X, Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 1996;271:1016-21 https://doi.org/10.1074/jbc.271.2.1016
- Colston KW, Perks CM, Xie SP, Holly JM. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 1998;20:157-62 https://doi.org/10.1677/jme.0.0200157
- Rozen F, Zhang J, Pollak M. Antiproliferative action of tumor necrosis factor on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol 1998;13:865-9
- Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377:646-9 https://doi.org/10.1038/377646a0
- Mochizuki S, Shimoda M, Shiomi T, Fujii Y, Okada Y. ADAM28 is activated by MMP-7(matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem Biophys Res Commun 2004;315:79-84 https://doi.org/10.1016/j.bbrc.2004.01.022
- Kübler B, Cowell S, Zapf J, Braulke T. Proteolysis of insulin- like growth factor binding proteins by a novel 50- kilodalton metalloproteinase in human pregnancy serum. Endocrinology 1998;139:1556-63 https://doi.org/10.1210/en.139.4.1556
- Kim HS, Ingermann AR, Tsubaki J, Twigg SM, Walker GE, Oh Y. Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor- mediated pathway in MCF-7 human breast cancer cells. Cancer Res 2004;64:2229-37 https://doi.org/10.1158/0008-5472.CAN-03-1675
- Butt AJ, Firth SM, King MA, Baxter RC. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiationinduced apoptosis in human breast cancer cells. J Biol Chem 2000;275:39174-81 https://doi.org/10.1074/jbc.M908888199
- Knudson AG Jr, Hethcote HW, Brown BW. Mutation and childhood cancer : a probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 1975;72:5116-20 https://doi.org/10.1073/pnas.72.12.5116
- Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutation in human cancers. Science 1991;253:49-53 https://doi.org/10.1126/science.1905840
- Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6 https://doi.org/10.1016/S0140-6736(97)10384-1
- Pratt SE, Pollak MN. Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulinlike growth factor-binding proteins in conditioned media. Cancer Res 1993;53:5193-8
- Mohan S, Bautista CM, Wergedal J, Baylink DJ. Isolation of an inhibitory insulin-like growth factor(IGF) binding protein from bone cell-conditioned medium : a potential local regulator of IGF action. Proc Natl Acad Sci USA 1989; 86:8338-42 https://doi.org/10.1073/pnas.86.21.8338
- Thiery J, Abouzahr S, Dorothee G, Jalil A, Richon C, Vergnon I, et al. p53 Potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathways. J Immunol 2005;174:871-8 https://doi.org/10.4049/jimmunol.174.2.871